Low serum vitamin D is a common clinical finding recorded in ICD 10 to reflect deficiency status and guide further evaluation. This coded condition helps clinicians communicate the severity and related complications associated with reduced circulating vitamin D levels.
Below is a structured overview of how low serum vitamin D is classified, documented, and managed in clinical practice using ICD 10 conventions.
| ICD 10 Code | Description | Associated Biomarker | Typical Clinical Context |
|---|---|---|---|
| E55.1 | Vitamin D deficiency | 25-hydroxyvitamin D < 20 ng/mL | Nutritional deficiency, malabsorption |
| E55.11 | Vitamin D deficiency due to malabsorption | 25-hydroxyvitamin D < 20 ng/mL | Celiac disease, bariatric surgery |
| E55.12 | Vitamin D deficiency due to chronic kidney disease | 25-hydroxyvitamin D < 20 ng/mL | Reduced renal 1-alpha hydroxylation |
| E55.13 | Vitamin D deficiency due to medications | 25-hydroxyvitamin D < 20 ng/mL | Anticonvulsants, glucocorticoids |
| Z87.891 | Personal history of vitamin D deficiency | N/A | Past documented low serum levels |
Understanding Low Serum Vitamin D in ICD 10 Coding
Low serum vitamin D in ICD 10 captures a range of deficiency states linked to inadequate intake, poor synthesis, or impaired metabolism. Accurate coding depends on identifying whether the cause is nutritional, malabsorptive, renal, or medication-related. Documentation of the serum 25-hydroxyvitamin D level supports precise code selection and medical necessity.
Clinicians rely on ICD 10 codes to reflect the underlying mechanism and guide treatment intensity. When low serum vitamin D is confirmed, providers must specify if it is isolated or associated with bone disease, such as osteomalacia. This level of detail ensures appropriate reimbursement and longitudinal tracking of the condition.
Laboratory thresholds are central to defining low serum vitamin D, with 25-hydroxyvitamin D under 20 ng/mL generally indicating deficiency. Codes are sequenced carefully to represent the etiology and any related complications. Consistent coding practices improve data quality for epidemiological studies and quality improvement initiatives.
Clinical Evaluation and Diagnostic Workup
Laboratory Assessment
Evaluation begins with measuring 25-hydroxyvitamin D, as it reflects both dietary and cutaneous sources. Ionized calcium, parathyroid hormone, phosphate, and alkaline phosphatase may be assessed to detect secondary hyperparathyroidism. In select cases, urine calcium and bone turnover markers provide additional insight into skeletal involvement.
Identifying Underlying Causes
A thorough history includes diet, sun exposure, gastrointestinal symptoms, medication use, and kidney function. Conditions such as celiac disease, Crohn disease, obesity, and chronic kidney disease contribute to low serum vitamin D and require specific management. Recognizing these drivers guides targeted therapy and monitoring.
Management Approaches and Monitoring
Replacement strategies vary by severity and etiology, with high-dose regimens often used for malabsorption and standard daily or weekly dosing for nutritional deficiency. Careful repletion is essential in patients with chronic kidney disease because of altered vitamin D activation. Serum calcium and 25-hydroxyvitamin D are typically rechecked to ensure adequacy and avoid hypercalcemia.
For medication-related low serum vitamin D, optimizing the dose when possible and selecting vitamin D analogs under supervision can mitigate risks. In chronic kidney disease, active metabolites and calcimimetics may be integrated into the plan. Long-term maintenance dosing is often required, especially when underlying causes persist.
Prognosis and Preventive Strategies
With appropriate correction, most patients show improved biochemical parameters and symptomatic relief. In populations with limited sun exposure, routine screening and seasonal supplementation can reduce the incidence of low serum vitamin D. Public health measures that promote fortified foods and safe outdoor activity further support population-level vitamin D status.
Key Takeaways for Clinicians and Coders
- Confirm low serum vitamin D with 25-hydroxyvitamin D testing before assigning ICD 10 codes.
- Select codes that reflect the etiology, such as malabsorption, chronic kidney disease, or medication effects.
- Document the relationship between low serum vitamin D and any underlying conditions in the medical record.
- Plan individualized repletion and monitoring strategies based on cause, severity, and comorbidities.
FAQ
Reader questions
What ICD 10 code should I use for low serum vitamin D without a specific cause?
Use E55.1 for documented vitamin D deficiency when the documentation does not specify a particular etiology. This code captures uncomplicated low serum vitamin D identified through laboratory testing.
How should low serum vitamin D due to malabsorption be coded and documented?
Assign E55.11 and link it clearly to the underlying condition, such as celiac disease or prior bariatric surgery. Explicit documentation connecting the malabsorption history to the vitamin D deficiency supports accurate coding and billing.
Is a separate code needed when low serum vitamin D is associated with chronic kidney disease?
Yes, report E55.12 when the medical record states that the low serum vitamin D is due to chronic kidney disease. Include N18 codes to capture the stage of kidney disease and show the relationship between the conditions.
What should be included in the follow-up plan after initiating replacement for low serum vitamin D?
Schedule repeat 25-hydroxyvitamin D testing at least once during the repletion phase and periodically thereafter for maintenance. Monitor calcium levels and clinical symptoms, and adjust long-term dosing based on laboratory results and patient tolerance.